ETHRA Pharmaceuticals continues to invest in active pharmaceutical ingredient (API) manufacturing as part of a vertically integrated supply strategy.
Supply Security
In-house API production reduces reliance on imported raw materials, shortens lead times, and improves cost predictability for finished medicines.
GMP API Operations
Our API unit operates under the same quality management framework as our dosage form lines, with documented synthesis, purification, and release testing.
Partnership Opportunities
Contract manufacturing and toll-processing enquiries from regional pharmaceutical companies are welcome.